Floatz logo

APABETALONE

Atherosclerosis

Resverlogix CorpSmall moleculePhase 1/2Dormant
CCC
50/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
37/ 100
Competitive Position
89/ 100

Competitive context

19 Active assets in the Atherosclerosis cohort.

Asset / SponsorPhaseRating
Acetylsalicylic Acid
Rajaie Cardiovascular Medical and Research Center
Phase 4BBB
SIMVASTATIN
Northern California Institute of Research and Education
Phase 4BBB
ADVICOR COMPONENT NIACIN
University of Washington
Phase 4BB
Lipitor
Erasmus Medical Center
Phase 4BB
6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydrocarbostyril
Asan Medical Center
Phase 4BB

View all 49 →

Same molecule, other indications

APABETALONE is also rated in:

inherited lipid metabolism disorderDormant
CCC
Indicative ·
52 / 100
View asset →
cardiovascular disorderDormant
CCC
Indicative ·
50 / 100
View asset →
acute coronary syndromeDormant
CCC
Indicative ·
48 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →